KDOAM-25 is a potent and highly selective inhibitor of histone lysine demethylase 5 (KDM5), with IC50 values of 71 nM, 19 nM, 69 nM, and 69 nM against KDM5A, KDM5B, KDM5C, and KDM5D, respectively; it increases global H3K4 methylation at transcription start sites and impairs the proliferation of multiple myeloma MM1S cells.